Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    IGM Biosciences Inc.

    NASDAQ: IGMS · Real-Time Price · USD
    1.24
    0.02 (1.64%)
    At close: Jun 17, 2025, 12:37 PM

    IGM Biosciences Statistics

    Share Statistics

    IGM Biosciences has 60.12M shares outstanding. The number of shares has increased by 1.27% in one year.

    Shares Outstanding

    n/a
    		 60.12M

    Shares Change (YoY)

    n/a
    		 1.27%

    Shares Change (QoQ)

    n/a
    		 0.52%

    Owned by Institutions (%)

    n/a
    		 35.74%

    Shares Floating

    n/a
    		 28.86M

    Failed to Deliver (FTD) Shares

    n/a
    		 2,879

    FTD / Avg. Volume

    n/a
    		 1.63%

    Short Selling Information

    The latest short interest is 773.45K, so 1.29% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 773.45K

    Short % of Shares Out

    n/a
    		 1.29%

    Short % of Float

    n/a
    		 3.95%

    Short Ratio (days to cover)

    n/a
    		 3.78

    Valuation Ratios

    The PE ratio is -1.89 and the forward PE ratio is -0.53. IGM Biosciences's PEG ratio is 0.06.

    PE Ratio

    n/a
    		 -1.89

    Forward PE

    n/a
    		 -0.53

    PS Ratio

    n/a
    		 138.02

    Forward PS

    n/a
    		 12.1

    PB Ratio

    n/a
    		 7.68

    P/FCF Ratio

    n/a
    		 -2.33

    PEG Ratio

    n/a
    		 0.06
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for IGM Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.14, with a Debt / Equity ratio of 0.94.

    Current Ratio

    n/a
    		 5.14

    Quick Ratio

    n/a
    		 5.14

    Debt / Equity

    n/a
    		 0.94

    Debt / EBITDA

    n/a
    		 -0.23

    Debt / FCF

    n/a
    		 -0.28

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $17,979.87

    Profits Per Employee

    n/a
    		 $-1,314,060.4

    Employee Count

    n/a
    		 149

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -83.17% in the last 52 weeks. The beta is 0.51, so IGM Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.51

    52-Week Price Change

    n/a
    		 -83.17%

    50-Day Moving Average

    n/a
    		 1.23

    200-Day Moving Average

    n/a
    		 6.23

    Relative Strength Index (RSI)

    n/a
    		 47.08

    Average Volume (20 Days)

    n/a
    		 177,065

    Income Statement

    In the last 12 months, IGM Biosciences had revenue of 2.68M and earned -195.79M in profits. Earnings per share was -3.24.

    Revenue

    n/a
    		 2.68M

    Gross Profit

    n/a
    		 -6.43M

    Operating Income

    n/a
    		 -208.58M

    Net Income

    n/a
    		 -195.79M

    EBITDA

    n/a
    		 -199.47M

    EBIT

    n/a
    		 -208.58M

    Earnings Per Share (EPS)

    n/a
    		 -3.24
    Full Income Statement

    Balance Sheet

    The company has 26.5M in cash and 45.19M in debt, giving a net cash position of -18.69M.

    Cash & Cash Equivalents

    n/a
    		 26.5M

    Total Debt

    n/a
    		 45.19M

    Net Cash

    n/a
    		 -18.69M

    Retained Earnings

    n/a
    		 -1.02B

    Total Assets

    n/a
    		 206.89M

    Working Capital

    n/a
    		 132.84M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -153M and capital expenditures -5.85M, giving a free cash flow of -158.85M.

    Operating Cash Flow

    n/a
    		 -153M

    Capital Expenditures

    n/a
    		 -5.85M

    Free Cash Flow

    n/a
    		 -158.85M

    FCF Per Share

    n/a
    		 -2.62
    Full Cash Flow Statement

    Margins

    Gross margin is -240.13%, with operating and profit margins of -7785.74% and -7308.51%.

    Gross Margin

    n/a
    		 -240.13%

    Operating Margin

    n/a
    		 -7785.74%

    Pretax Margin

    n/a
    		 -7308.51%

    Profit Margin

    n/a
    		 -7308.51%

    EBITDA Margin

    n/a
    		 -7445.61%

    EBIT Margin

    n/a
    		 -7785.74%

    FCF Margin

    n/a
    		 -5929.38%

    Dividends & Yields

    IGMS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for IGMS is $2, which is 62.6% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $2

    Price Target Difference

    n/a
    		 62.6%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 8
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -9.23

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist